tirzepatide breastfeeding data If you're on a GLP-1 medication and pregnant or breastfeeding- this one's for you. 👇Here's what the current research says: 💉 Semaglutide- not detected in breast milk 3.5 hours after injection. Reassuring Tirzepatide While Breastfeeding: Safety &

Nevertheless, any new or worsening hair loss during treatment warrants discussion with a GP or prescriber to rule out other contributing causes, such as nutritional deficiencies or thyroid dysfunction

Your clinician may adjust your dosage tier over time based on your response, goals, and clinical assessment

Planning accordingly helps preserve the gains you have worked to achieve

Future research should characterize GIPR with single-cell ocular transcriptomics, directly compare Tirzepatide with pure GLP-1 RAs for IOP and retinal outcomes across metabolic contexts, and incorporate ophthalmic endpoints in cardiometabolic trials to better define the risk-benefit profile

Weight loss trajectory and appetite at different phases Weight loss with retatrutide follows a characteristic pattern: Months 1-3: Slow start during dose escalation, transitioning to accelerating weight loss as appetite suppression establishes

Exercise: Start or maintain a basic exercise routine